At this time, posts about Crystal are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 15,000 shares today. Crystal is known as a company specializing in new drug development, including arthritis treatments and novel antibiotics.


As of 11:30 AM on the 16th, Crystal's stock price is 20,150 KRW, up 3.33% from the previous day, with a trading volume of 2,766,656 shares, which is 132.73% of the 5-day average trading volume.


In addition to Crystal, posts by investors are also rapidly increasing for Korea Financial Group Preferred (071055), NextBT (065170), and Youngjin Pharm (003520).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing